NT-proBNP variation in stable pulmonary arterial hypertension patients.

I. Furtado (Porto, Portugal), C. Cruz (Porto, Portugal), A. Vigário (Porto, Portugal), S. Correia (Braga, Portugal), L. Carvalho (Porto, Portugal), F. Gonçalves (Porto, Portugal), M. Santos (Porto, Portugal), A. Reis (Porto, Portugal)

Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Session: Pulmonary hypertension in lung diseases and the role of the right ventricle
Session type: Thematic Poster
Number: 3112
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Furtado (Porto, Portugal), C. Cruz (Porto, Portugal), A. Vigário (Porto, Portugal), S. Correia (Braga, Portugal), L. Carvalho (Porto, Portugal), F. Gonçalves (Porto, Portugal), M. Santos (Porto, Portugal), A. Reis (Porto, Portugal). NT-proBNP variation in stable pulmonary arterial hypertension patients.. 3112

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
NT-proBNP correlates with RVEF in patients suffering from pulmonary arterial hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 110s
Year: 2004

Plasma big-endothelin and hemodynamics in patients with pulmonary arterial hypertension compared to patients with chronic left heart failure with and without pulmonary venous hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

Is there a fixed relationship between the mean and systolic pulmonary artery pressures in idiopathic pulmonary arterial hypertension (IPAH) and proximal chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009

6MWD in patients with pulmonary arterial hypertension (PAH)
Source: Eur Respir J 2003; 22: Suppl. 45, 464s
Year: 2003

Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009


Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension
Source: Eur Respir J 2009; 34: 770
Year: 2009


Pulmonary arterial pressure predicts nocturnal hypoxemia in CTEPH patients.
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018


Patterns of mean pulmonary artery pressure (mPAP)-flow relation changes following chronic therapy in idiopathic pulmonary arterial hypertension (IPAH)
Source: Eur Respir J 2006; 28: Suppl. 50, 427s
Year: 2006

The influence of fractional pulse pressure on the outcome of pulmonary thromboendarterectomy
Source: Eur Respir J 2001; 17: 653-659
Year: 2001



Hemodynamic effects of sildenafil in pulmonary arterial hypertension (PAH) patients
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005


Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011



Pulmonary pressure at rest and during slight exercise might have prognostic relevance in patients at risk for pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008


Apelin improves cardiac output in patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015

Functional impact of exercise pulmonary hypertension in patients with borderline pulmonary arterial pressure
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017

The association between resting and mild-to-moderate exercise pulmonary artery pressure
Source: Eur Respir J 2012; 39: 313-318
Year: 2012



Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012


Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

Arterial stiffness in patients with chronic obstructive pulmonary disease combined with arterial hypertension
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020


Differences of right ventricular diastolic stiffness in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019